Skip to main content

Advertisement

Log in

Phase II trial of Echinomycin in advanced hormone-resistant prostate cancer

An Illinois Cancer Council study

  • Published:
Investigational New Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Martin DG, Mizsak SA, Biles C, Steward JC, Bacynskyj L, Meulman PA: Structure of quinomycin antibiotics. J Antibiot (Tokyo) 28:332–336, 1975

    Google Scholar 

  2. Lathan B, Von Hoff DD: Cytotoxin activity of Echinomycin in a human tumor cloning system. Cancer Drug Delivery 1:191–198, 1984

    Google Scholar 

  3. Shafer RH, Waring MJ: DNA bis-intercalation: application of theory to the binding of Echinomycin to DNA. Biopolymers 19:431–443, 1980

    Google Scholar 

  4. Waring MJ, Wakelin LPG: Echinomycin: a bifunctional intercalating antibiotic. Nature 252:653–657, 1984

    Google Scholar 

  5. Harvey HH, McFadden M, Andrews WG, Byrne PJ, Ahlgren JD, Woolley PV: Phase I study of Echinomycin administered on an intermittent bolus schedule. Cancer Treat Rep 69:1365–1368, 1985

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shevrin, D.H., Lad, T.E., Guinan, P. et al. Phase II trial of Echinomycin in advanced hormone-resistant prostate cancer. Invest New Drugs 12, 65–66 (1994). https://doi.org/10.1007/BF00873239

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00873239

Key words

Navigation